{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:36:56Z","timestamp":1768869416808,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA044853"],"award-info":[{"award-number":["K01DA044853"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10461-025-04841-5","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T03:47:32Z","timestamp":1754538452000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Dyad-Based Intervention to Improve Adherence to Antiretroviral Therapy among People with HIV who Inject Drugs in Kazakhstan: Results of a Randomized Controlled Trial"],"prefix":"10.1007","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct03555396","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2084-9741","authenticated-orcid":false,"given":"Alissa","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rozental","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niall","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valera","family":"Gulyayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Gulyayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfiya","family":"Denebayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assel","family":"Terlikbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sholpan","family":"Primbetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackelyn","family":"Samandas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Remien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaukhar","family":"Mergenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"9","key":"4841_CR1","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2352-3018(23)00150-9","volume":"10","author":"JB Nachega","year":"2023","unstructured":"Nachega JB, Musoke P, Kilmarx PH, Gandhi M, Grinsztejn B, Pozniak A, et al. Global HIV control: is the glass half empty or half full? Lancet HIV. 2023;10(9):e617\u201322.","journal-title":"Lancet HIV"},{"issue":"8","key":"4841_CR2","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","volume":"103","author":"M Malta","year":"2008","unstructured":"Malta M, Strathdee SA, Magnanini MMF, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242\u201357.","journal-title":"Addiction"},{"issue":"2","key":"4841_CR3","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","volume":"104","author":"KM Keyes","year":"2014","unstructured":"Keyes KM, Cerd\u00e1 M, Brady JE, Havens JR, Galea S. Understanding the Rural\u2013Urban differences in nonmedical prescription opioid use and abuse in the united States. Am J Public Health. 2014;104(2):e52\u20139.","journal-title":"Am J Public Health"},{"key":"4841_CR4","volume-title":"UNAIDS data 2022","author":"UNAIDS","year":"2022","unstructured":"UNAIDS. UNAIDS data 2022. Geneva: UNAIDS; 2022."},{"key":"4841_CR5","unstructured":"UNAIDS. UNAIDS Data 2021 [Internet]. Geneva: UNAIDS. 2021 Nov. Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021_unaids_data"},{"issue":"7","key":"4841_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1473-3099(10)70118-3","volume":"10","author":"C Thorne","year":"2010","unstructured":"Thorne C, Ferencic N, Malyuta R, Mimica J, Niemiec T. Central asia: hotspot in the worldwide HIV epidemic. Lancet Infect Dis. 2010;10(7):479\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4841_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11904-014-0202-3","volume":"11","author":"J DeHovitz","year":"2014","unstructured":"DeHovitz J, Uuskula A, El-Bassel N. The HIV epidemic in Eastern Europe and central Asia. Curr HIV\/AIDS Rep. 2014;11(2):168\u201376.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"7","key":"4841_CR8","doi-asserted-by":"publisher","first-page":"e0305086","DOI":"10.1371\/journal.pone.0305086","volume":"19","author":"TD Ottesen","year":"2024","unstructured":"Ottesen TD, Wickersham JA, Lawrence JC, Antoniak S, O Zezuilin, Polonsky M et al. GO Dida editor 2024 High rates of deferring antiretroviral treatment for patients with HIV and substance use disorders: results from a National sample of HIV physicians in Ukraine. PLoS ONE 19 7 e0305086.","journal-title":"PLoS ONE"},{"issue":"4","key":"4841_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.drugpo.2007.01.012","volume":"18","author":"D Wolfe","year":"2007","unstructured":"Wolfe D. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet union. Int J Drug Policy. 2007;18(4):246\u201354.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"4841_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0274-2","volume":"16","author":"AP Deryabina","year":"2019","unstructured":"Deryabina AP, Patnaik P, El-Sadr WM. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm Reduct J. 2019;16(1):1.","journal-title":"Harm Reduct J"},{"key":"4841_CR11","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.drugalcdep.2013.06.034","volume":"132","author":"ML McNairy","year":"2013","unstructured":"McNairy ML, Deryabina A, Hoos D, El-Sadr WM. Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in central Asia. Drug Alcohol Depend. 2013;132:S65\u201370.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"4841_CR12","doi-asserted-by":"publisher","first-page":"ofw219","DOI":"10.1093\/ofid\/ofw219","volume":"4","author":"EG Ferro","year":"2017","unstructured":"Ferro EG, Culbert GJ, Wickersham JA, Marcus R, Steffen AD, Pauls HA, et al. Physician decisions to defer antiretroviral therapy in key populations: implications for reducing human immunodeficiency virus incidence and mortality in Malaysia. Open Forum Infect Dis. 2017;4(1):ofw219.","journal-title":"Open Forum Infect Dis"},{"key":"4841_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/PPA.S192735","volume":"13","author":"F Altice","year":"2019","unstructured":"Altice F, Evuarherhe O, Shina S, Carter G, Beaubrun AC. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. PPA. 2019;13:475\u201390.","journal-title":"PPA"},{"issue":"9651","key":"4841_CR14","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345.","journal-title":"Lancet"},{"issue":"2","key":"4841_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11904-010-0043-7","volume":"7","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and Non-injecting drug users: current trends and implications for interventions. Curr HIV\/AIDS Rep. 2010;7(2):99\u2013106.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"4841_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/105504901750160501","volume":"10","author":"A Kelly Avants","year":"2001","unstructured":"Kelly Avants A, Margolin, Lara S. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict. 2001;10(1):69\u201378.","journal-title":"Am J Addict"},{"issue":"2","key":"4841_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","volume":"84","author":"A Palepu","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, et al. Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84(2):188\u201394.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4841_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00042560-200107010-00006","volume":"27","author":"GM Lucas","year":"2001","unstructured":"Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. JAIDS J Acquir Immune Defic Syndr. 2001;27(3):251\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"4","key":"4841_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.qai.0000186392.26334.e3","volume":"41","author":"A Knowlton","year":"2006","unstructured":"Knowlton A, Arnsten J, Eldred L, Wilkinson J, Gourevitch M, Shade S, et al. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. JAIDS J Acquir Immune Defic Syndr. 2006;41(4):486\u201392.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"4841_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/135965350400900218","volume":"9","author":"E Wood","year":"2004","unstructured":"Wood E, Montaner JSG, Yip B, Tyndall MW, Schechter MT, O\u2019Shaughnessy MV, et al. Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther. 2004;9(2):229\u201335.","journal-title":"Antivir Ther"},{"issue":"9738","key":"4841_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(10)61026-4","volume":"376","author":"N El-Bassel","year":"2010","unstructured":"El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. Lancet. 2010;376(9738):312\u20134.","journal-title":"Lancet"},{"issue":"10","key":"4841_CR22","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1007\/s10461-014-0827-7","volume":"18","author":"T Jiwatram-Negr\u00f3n","year":"2014","unstructured":"Jiwatram-Negr\u00f3n T, El-Bassel N. Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions. AIDS Behav. 2014;18(10):1864\u201387.","journal-title":"AIDS Behav"},{"issue":"4","key":"4841_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s10461-020-03019-5","volume":"25","author":"PL Marotta","year":"2021","unstructured":"Marotta PL, Gilbert L, Goddard-Eckrich D, Hunt T, Metsch L, Davis A, et al. A dyadic analysis of criminal justice involvement and sexual HIV risk behaviors among drug-involved men in community corrections and their intimate partners in new York city: implications for prevention, treatment and policies. AIDS Behav. 2021;25(4):1047\u201362.","journal-title":"AIDS Behav"},{"key":"4841_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugpo.2018.08.014","volume":"62","author":"A Davis","year":"2018","unstructured":"Davis A, McCrimmon T, Dasgupta A, Gilbert L, Terlikbayeva A, Hunt T, et al. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Int J Drug Policy. 2018;62:43\u201350.","journal-title":"Int J Drug Policy"},{"issue":"8","key":"4841_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.aids.0000168975.44219.45","volume":"19","author":"RH Remien","year":"2005","unstructured":"Remien RH, Stirratt MJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19(8):807\u201314.","journal-title":"AIDS"},{"issue":"5","key":"4841_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10461-006-9106-6","volume":"10","author":"MJ Stirratt","year":"2006","unstructured":"Stirratt MJ, Remien RH, Smith A, Copeland OQ, Dolezal C, Krieger D, et al. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10(5):483\u201393.","journal-title":"AIDS Behav"},{"issue":"Supplement 1","key":"4841_CR27","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/01.qai.0000248340.20685.7d","volume":"43","author":"RH Remien","year":"2006","unstructured":"Remien RH, Stirratt MJ, Dognin J, Day E, El-Bassel N, Warne P. Moving from theory to research to practice: implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients. JAIDS J Acquir Immune Defic Syndr. 2006;43(Supplement 1):S69\u201378.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"4841_CR28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s10461-013-0438-8","volume":"17","author":"RH Remien","year":"2013","unstructured":"Remien RH, Mellins CA, Robbins RN, Kelsey R, Rowe J, Warne P, et al. Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav. 2013;17(6):1979\u201391.","journal-title":"AIDS Behav"},{"issue":"10","key":"4841_CR29","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1007\/s10461-018-2145-y","volume":"22","author":"H Gouse","year":"2018","unstructured":"Gouse H, Robbins RN, Mellins CA, Kingon A, Rowe J, Henry M, et al. Empowering Lay-Counsellors with technology: masivukeni, a standardized multimedia counselling support tool to deliver ART counselling. AIDS Behav. 2018;22(10):3345\u201356.","journal-title":"AIDS Behav"},{"issue":"3","key":"4841_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/10497315221117543","volume":"33","author":"A Davis","year":"2023","unstructured":"Davis A, Mergenova G, Landers SE, Sun Y, Rozental E, Gulyaev V, et al. Implementation of a Dyad-Based intervention to improve antiretroviral therapy adherence among HIV-Positive people who inject drugs in kazakhstan: A randomized trial. Res Social Work Pract. 2023;33(3):313\u201324.","journal-title":"Res Social Work Pract"},{"issue":"12","key":"4841_CR31","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1007\/s10461-019-02421-y","volume":"23","author":"A Davis","year":"2019","unstructured":"Davis A, Sarsembayeva L, Gulyaev V, Primbetova S, Terlikbayeva A, Mergenova G, et al. If you build it, will they use it?? Preferences for antiretroviral therapy (ART) adherence monitoring among people who it?nject drugs (PWID) in Kazakhstan. AIDS Behav. 2019;23(12):3294\u2013305.","journal-title":"AIDS Behav"},{"issue":"11","key":"4841_CR32","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s10461-016-1406-x","volume":"20","author":"IB Wilson","year":"2016","unstructured":"Wilson IB, Lee Y, Michaud J, Fowler FJ, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700\u20138.","journal-title":"AIDS Behav"},{"issue":"3","key":"4841_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/apc.2010.0314","volume":"25","author":"K Lehavot","year":"2011","unstructured":"Lehavot K, Huh D, Walters KL, King KM, Andrasik MP, Simoni JM. Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care STDS. 2011;25(3):181\u20139.","journal-title":"AIDS Patient Care STDS"},{"key":"4841_CR34","unstructured":"Kenny DA, Funder DC. Interpersonal perception: the foundation of social relationships. Second edition. New York: The Guilford Press; 2020. 1 p."},{"key":"4841_CR35","first-page":"458","volume-title":"Dyadic data analysis","author":"DA Kenny","year":"2006","unstructured":"Kenny DA, Kashy DA, Cook WL. Dyadic data analysis. New York: Guilford Press; 2006. p. 458. (Methodology in the social sciences)."},{"issue":"1","key":"4841_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1748-5908-3-2","volume":"3","author":"F L\u00e9gar\u00e9","year":"2008","unstructured":"L\u00e9gar\u00e9 F, Elwyn G, Fishbein M, Fr\u00e9mont P, Frosch D, Gagnon MP, et al. Translating shared decision-making into health care clinical practices: proof of concepts. Implement Sci. 2008;3(1):2.","journal-title":"Implement Sci"},{"issue":"2","key":"4841_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0265407596132007","volume":"13","author":"DA Kenny","year":"1996","unstructured":"Kenny DA. Models of Non-Independence in dyadic research. J Soc Pers Relationsh. 1996;13(2):279\u201394.","journal-title":"J Soc Pers Relationsh"},{"key":"4841_CR38","first-page":"256","volume-title":"Intensive longitudinal methods: an introduction to diary and experience sampling research","author":"N Bolger","year":"2013","unstructured":"Bolger N, Laurenceau JP. Intensive longitudinal methods: an introduction to diary and experience sampling research. New York: Guilford Press; 2013. p. 256. Methodology in the social sciences)."},{"issue":"1","key":"4841_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B: Stat Methodol. 1995;57(1):289\u2013300.","journal-title":"J Royal Stat Soc Ser B: Stat Methodol"},{"issue":"4","key":"4841_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2975\/27.2004.392.401","volume":"27","author":"P Solomon","year":"2004","unstructured":"Solomon P. Peer support\/peer provided services underlying processes, benefits, and critical ingredients. Psychiatr Rehabil J. 2004;27(4):392\u2013401.","journal-title":"Psychiatr Rehabil J"},{"issue":"9","key":"4841_CR41","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/09540121.2020.1826396","volume":"33","author":"S Dasgupta","year":"2021","unstructured":"Dasgupta S, Tie Y, Lemons-Lyn A, Broz D, Buchacz K, Shouse RL. HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services. AIDS Care. 2021;33(9):1146\u201354.","journal-title":"AIDS Care"},{"issue":"9737","key":"4841_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268\u201384.","journal-title":"Lancet"},{"issue":"2","key":"4841_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"4841_CR44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10461-018-2244-9","volume":"23","author":"LD Mitzel","year":"2019","unstructured":"Mitzel LD, VanderDrift LE, Ioerger M, Vanable PA. The effect of partner serostatus and relationship duration on HIV medication adherence. AIDS Behav. 2019;23(2):499\u2013503.","journal-title":"AIDS Behav"},{"issue":"2","key":"4841_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1258\/ijsa.2008.008418","volume":"21","author":"N Kumarasamy","year":"2010","unstructured":"Kumarasamy N, Venkatesh KK, Srikrishnan AK, Prasad L, Balakrishnan P, Murugavel KG, et al. Couples at risk for HIV infection in Southern india: characteristics of HIV-infected patients in concordant and discordant heterosexual relationships. Int J STD AIDS. 2010;21(2):96\u2013100.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"4841_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/09540121.2014.991269","volume":"27","author":"KE Gamarel","year":"2015","unstructured":"Gamarel KE, Neilands TB, Dilworth SE, Taylor JM, Johnson MO. Smoking, internalized heterosexism, and HIV disease management among male couples. AIDS Care. 2015;27(5):649\u201354.","journal-title":"AIDS Care"},{"issue":"9","key":"4841_CR47","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1080\/09540121.2011.554516","volume":"23","author":"AR Knowlton","year":"2011","unstructured":"Knowlton AR, Yang C, Bohnert A, Wissow L, Chander G, Arnsten JA. Main partner factors associated with worse adherence to HAART among women in baltimore, maryland: a preliminary study. AIDS Care. 2011;23(9):1102\u201310.","journal-title":"AIDS Care"},{"issue":"4","key":"4841_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10461-014-0927-4","volume":"19","author":"S Viswanathan","year":"2015","unstructured":"Viswanathan S, Detels R, Mehta SH, Macatangay BJC, Kirk GD, Jacobson LP. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART). AIDS Behav. 2015;19(4):601\u201311.","journal-title":"AIDS Behav"},{"issue":"9","key":"4841_CR49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/QAD.0b013e32832ba8ec","volume":"23","author":"EM Gardner","year":"2009","unstructured":"Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009;23(9):1035\u201346.","journal-title":"AIDS"},{"issue":"11","key":"4841_CR50","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1086\/430005","volume":"191","author":"N Beerenwinkel","year":"2005","unstructured":"Beerenwinkel N, D\u00e4umer M, Sing T, Rahnenf\u00fchrer J, Lengauer T, Selbig J, et al. Estimating HIV evolutionary pathways and the genetic barrier to drug resistance. J INFECT DIS. 2005;191(11):1953\u201360.","journal-title":"J INFECT DIS"},{"issue":"3","key":"4841_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAD.0b013e328335cd8a","volume":"24","author":"EM Gardner","year":"2010","unstructured":"Gardner EM, Hullsiek KH, Telzak EE, Sharma S, Peng G, Burman WJ, et al. Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial. AIDS. 2010;24(3):395\u2013403.","journal-title":"AIDS"},{"issue":"1","key":"4841_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10461-005-1685-0","volume":"9","author":"CA Bova","year":"2005","unstructured":"Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103\u201310.","journal-title":"AIDS Behav"},{"issue":"8","key":"4841_CR53","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1086\/323201","volume":"33","author":"JH Arnsten","year":"2001","unstructured":"Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang C, et al. Antiretroviral therapy adherence and viral suppression in HIV-Infected drug users: comparison of self\u2010report and electronic monitoring. CLIN INFECT DIS. 2001;33(8):1417\u201323.","journal-title":"CLIN INFECT DIS"},{"issue":"8","key":"4841_CR54","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s10461-019-02448-1","volume":"23","author":"L Craker","year":"2019","unstructured":"Craker L, Tarantino N, Whiteley L, Brown L. Measuring antiretroviral adherence among young people living with HIV: observations from a real-time monitoring device versus Self-report. AIDS Behav. 2019;23(8):2138\u201345.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04841-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04841-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04841-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:02:08Z","timestamp":1768824128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04841-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4841"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04841-5","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"20 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}